BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12544821)

  • 1. Opioid-induced hyperalgesia: abnormal or normal pain?
    Simonnet G; Rivat C
    Neuroreport; 2003 Jan; 14(1):1-7. PubMed ID: 12544821
    [No Abstract]   [Full Text] [Related]  

  • 2. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain.
    Mao J; Mayer DJ
    Ann N Y Acad Sci; 2001 Mar; 933():175-84. PubMed ID: 12000019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: role of protein kinase C and N-methyl-D-aspartate receptors.
    Song L; Wu C; Zuo Y
    BMC Anesthesiol; 2015; 15():12. PubMed ID: 25745356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
    Zhao M; Joo DT
    Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioid tolerance: a phenomenon of latent hyperalgesia].
    Gao JL; Zhou WH; Yang GD
    Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):265-8. PubMed ID: 12545806
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z; Han H; Cao J; Xu L
    Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid tolerance in neonates: a state-of-the-art review.
    Suresh S; Anand KJ
    Paediatr Anaesth; 2001; 11(5):511-21. PubMed ID: 11696114
    [No Abstract]   [Full Text] [Related]  

  • 12. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
    Terashvili M; Wu HE; Schwasinger E; Tseng LF
    Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
    Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
    Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical relevance of opioid-induced hyperalgesia remains unresolved].
    Sørensen J; Sjøgren P
    Ugeskr Laeger; 2011 Mar; 173(13):965-8. PubMed ID: 21453637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.
    Dumas EO; Pollack GM
    AAPS J; 2008 Dec; 10(4):537-51. PubMed ID: 18989788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.
    Juni A; Cai M; Stankova M; Waxman AR; Arout C; Klein G; Dahan A; Hruby VJ; Mogil JS; Kest B
    Anesthesiology; 2010 Jan; 112(1):181-8. PubMed ID: 19996949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of opioid-induced tolerance and hyperalgesia.
    DuPen A; Shen D; Ersek M
    Pain Manag Nurs; 2007 Sep; 8(3):113-21. PubMed ID: 17723928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of synaptic long-term potentiation after opioid withdrawal.
    Drdla R; Gassner M; Gingl E; Sandkühler J
    Science; 2009 Jul; 325(5937):207-10. PubMed ID: 19590003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.